Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Vivek Subbiah
Dec 4, 2023, 15:54 |
Blog
Vivek Subbiah: Tissue-agnostic precision medicine takes the spotlight!
Vivek Subbiah shared a post on his LinkedIn page: "Hot off the press- Friday Motivation!…
Nov 29, 2023, 16:31 |
Drugs
Vivek Subbiah: Our review on management of FGFR inhibitor toxicities
Vivek Subbiah shared on LinkedIn: "Pleased to share our review on management of FGFR inhibitor…
Nov 28, 2023, 16:43 |
Drugs
Vivek Subbiah: Pleased to share our review on RET inhibitors
Vivek Subbiah shared on LinkedIn: "Pleased to share our review on RET inhibitors and RET inhibitor…
Nov 27, 2023, 17:17 |
Insight
Vivek Subbiah: Treatment patterns and overall survival (OS) in patients with advanced NSCLC in three countries between 2011 and 2020
Vivek Subbiah shared on LinkedIn: “Pleased to share our paper in American Cancer Society journal…
Nov 26, 2023, 15:32 |
Blog
Vivek Subbiah: This review delves into the evolution of basket trials in cancer drug development
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on LinkedIn:…
Nov 22, 2023, 02:38 |
Blog
Vivek Subbiah: When JAMA publishes a phase 1 study, it will be a practice-changing study in the future- Lepodisiran
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on…
Nov 21, 2023, 13:57 |
Blog
Vivek Subbiah: Honored to co-author with brilliant "Guru" of bladder cancer Guru Sonpavde.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 20, 2023, 03:35 |
Insight
Vivek Subbiah: This Review summarizes the evidence regarding the use of VAF as a predictive biomarker
Vivek Subbiah shared on LinkedIn: "Pleased to share our paper in Cell Press Journal Trends…
Nov 13, 2023, 19:33 |
Blog
Vivek Subbiah: Think Tank on Advancing precision medicine in Rare cancers spearheaded by the amazing Jim Palma and Razelle Kurzrock
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 13, 2023, 12:58 |
Blog
Vivek Subbiah: Incredible meeting of the Early Phase Drug Development minds
Vivek Subbiah shared on LinkedIn: “Wow! Incredible meeting of the Early Phase Drug Development minds.…
19
20
21
22
23
All:
325
Posts:
201 - 210
43 Posts Not To Miss From ESMO24 Day 2
45 Posts not to miss from ESMO24 Day 1
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube